The intramuscular administration of granulocyte colony-stimulating factor as an adjunct to chemotherapy in pretreated ovarian cancer patients: an Italian Trials in Medical Oncology (ITMO) Group pilot study.

No published data are available concerning the activity and tolerability of intramuscularly administered granulocyte colony-stimulating factor (G-CSF) in humans. To fill this gap, 19 patients with advanced ovarian cancer previously treated with at least one first-line chemotherapy cycle received the...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Leo, A., Bajetta, E., Nolè, F., Biganzoli, L., Ferrari, L., Oriana, S., Riboldi, G., Bohm, S., Spatti, G., Raspagliesi, F.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968904/
https://www.ncbi.nlm.nih.gov/pubmed/7514030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968904/
https://www.ncbi.nlm.nih.gov/pubmed/7514030

Ejemplares similares